Sigrima 420mg Injection

420mg Injection , Vial

4.5 (154)

80,000

Sigrima 420mg Injection is a monoclonal antibody used to treat HER2-positive breast cancer. It works by targeting the HER2 protein on cancer cells, helping slow or stop their growth and spread. The injection is administered intravenously under the supervision of a healthcare professional. Common side effects include nausea, diarrhea, fatigue, and hair loss. Regular monitoring of blood counts and heart, liver, and kidney function may be required during treatment. Use this medicine exactly as prescribed by your doctor for the best outcomes.

Description

Introduction Of Sigrima 420mg Injection:

Sigrima 420mg Injection is used to treat breast cancer. It belongs to group of medicine called monoclonal antibodies.

Sigrima 420mg Injection is given as an injection into veins under the supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Hair loss, diarrhea, nausea, and fatigue are some common side effects of this medicine. This medicine may reduce the number of blood cells (decrease white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with the heart, liver, and kidney.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Uses Of Sigrima 420mg Injection:

  • Breast cancer

Benefits Of Sigrima 420mg Injection:

In Breast cancer Sigrima 420mg Injection is used to treat breast cancer when other medicines have failed to show significant improvement. It helps to stop cancer growth and further spread and relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. This medicine is given as an injection by a doctor or nurse. Follow your doctor’s instructions carefully to get the most benefit.

Mechanism Of Action Sigrima 420mg Injection:

Sigrima 420mg Injection is a monoclonal antibody designed to recognize and attach to specific proteins on the surface of cancer cells. Sigrima 420mg Injection gets attached to human epidermal growth factor receptor 2 (HER2) and may kill or stop the growth of cancer cells.

Contact Us

Info Table
Packaging Size Vial
Shelf Life 24 Month to 36 Month
Storage Temperature Store in a refrigerator (2 – 8 DegreeC). Do not freeze.
Storage Condition Store in a refrigerator (2 – 8 DegreeC). Do not freeze.
COMPOSITION Pertuzumab
Country of Origin Made in India
Vendor Info
Benefits
Reviews

Description

Introduction Of Sigrima 420mg Injection:

Sigrima 420mg Injection is used to treat breast cancer. It belongs to group of medicine called monoclonal antibodies.

Sigrima 420mg Injection is given as an injection into veins under the supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Hair loss, diarrhea, nausea, and fatigue are some common side effects of this medicine. This medicine may reduce the number of blood cells (decrease white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with the heart, liver, and kidney.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Uses Of Sigrima 420mg Injection:

  • Breast cancer

Benefits Of Sigrima 420mg Injection:

In Breast cancer Sigrima 420mg Injection is used to treat breast cancer when other medicines have failed to show significant improvement. It helps to stop cancer growth and further spread and relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. This medicine is given as an injection by a doctor or nurse. Follow your doctor’s instructions carefully to get the most benefit.

Mechanism Of Action Sigrima 420mg Injection:

Sigrima 420mg Injection is a monoclonal antibody designed to recognize and attach to specific proteins on the surface of cancer cells. Sigrima 420mg Injection gets attached to human epidermal growth factor receptor 2 (HER2) and may kill or stop the growth of cancer cells.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Sigrima 420mg Injection”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Sigrima 420mg Injection used for?
Sigrima 420mg (Pertuzumab) is a monoclonal antibody used together with Trastuzumab and chemotherapy (docetaxel) to treat HER2-positive breast cancer, including early-stage disease before surgery and advanced or metastatic cases.
Pertuzumab may cause serious or life-threatening heart problems, including heart failure. Your doctor will check your heart function before and during treatment. Symptoms like shortness of breath, swelling of the legs or face, rapid heartbeat, sudden weight gain, or dizziness should be reported to your doctor immediately.
Pertuzumab works by inhibiting HER2 from pairing with other HER receptors on cancer cells, which blocks the signaling that promotes cancer cell growth and division, helping stop or slow the spread of cancer.
It is given as an intravenous infusion under the supervision of a doctor or nurse, after being properly diluted. It should never be self-administered.
This medicine is not recommended during pregnancy, as it may harm an unborn baby. Effective contraception is required during treatment and for 7 months after the final dose. Regular monitoring of heart, liver, and kidney function, along with blood cell counts, is typically required throughout treatment.
Each vial contains 420mg of Pertuzumab (30mg/ml), manufactured by Zydus Lifesciences Limited, supplied as a 14ml vial, made in India.

Related products